Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilango Balakrishnan

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Oncotarget|July 25, 2016
Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastomaEric W Prince, Ilango Balakrishnan, Monil Shah, et al.
Neuro-Oncology|May 15, 2025
Targeting processive transcription for Myc-driven circuitry in medulloblastomaLays Martin Sobral, Faye M Walker, Krishna Madhavan, et al.
Cancer Research|May 27, 2025
Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline GliomaIlango Balakrishnan, Krishna Madhavan, Angela Pierce, et al.
Neuro-Oncology|May 17, 2017
NF-κB upregulation through epigenetic silencing of LDOC1 drives tumor biology and specific immunophenotype in Group A ependymomaAndrea M Griesinger, Davis A Witt, Sydney T Grob, et al.
Cell Reports|October 21, 2020
Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPGIlango Balakrishnan, Etienne Danis, Angela Pierce, et al.
Oncogene|January 24, 2020
Correction: BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathwayAdam L Green, John DeSisto, Patrick Flannery, et al.
Oncogene|December 18, 2019
BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathwayAdam L Green, John DeSisto, Patrick Flannery, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Oncotarget|July 25, 2016
Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastomaEric W Prince, Ilango Balakrishnan, Monil Shah, et al.
Neuro-Oncology|May 15, 2025
Targeting processive transcription for Myc-driven circuitry in medulloblastomaLays Martin Sobral, Faye M Walker, Krishna Madhavan, et al.
Cancer Research|May 27, 2025
Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline GliomaIlango Balakrishnan, Krishna Madhavan, Angela Pierce, et al.
Neuro-Oncology|May 17, 2017
NF-κB upregulation through epigenetic silencing of LDOC1 drives tumor biology and specific immunophenotype in Group A ependymomaAndrea M Griesinger, Davis A Witt, Sydney T Grob, et al.
Cell Reports|October 21, 2020
Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPGIlango Balakrishnan, Etienne Danis, Angela Pierce, et al.
Oncogene|January 24, 2020
Correction: BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathwayAdam L Green, John DeSisto, Patrick Flannery, et al.
Oncogene|December 18, 2019
BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathwayAdam L Green, John DeSisto, Patrick Flannery, et al.
Pageof 3